Connect with us

International

The Race for Solar Energy: Which Countries Are Winning?

Does the U.S. produce enough solar energy to power your coffee machine?

Published

on

Does the U.S. produce enough solar energy to power your coffee machine?

One thing that has never shut down during the pandemic is the sun, and thanks to the sun, in 2020 the world added enough new solar energy generation to power more than 95 million homes.

That’s 127 gigawatts, or 127 billion watts, of solar power added, according to the International Renewable Energy Agency, an intergovernmental organization that supports countries in their transition to sustainable energy.

But are we moving fast enough? According to IRENA, we need to step it up if the world wants to align the energy production with the Paris Accord -- wherein it was agreed countries would work to keep the increase in global average temperature to less than 1.5°C. above pre-industrial levels.

Costs of solar and other renewables are falling, clean tech markets are growing and the benefits of the renewables become more clear. Even with the challenges of the pandemic, the numbers offer promise of a cleaner energy landscape.

According to IRENA’s 2021 renewable energy capacity statistics, the U.S. has an installed capacity of about 76,000 megawatts (or 76 billion watts—a megawatt is a million watts) of solar power, about 10.6% of the world’s total capacity. To put the numbers in perspective, by most rough estimates it’s enough to power 57 million homes. That amount translates to about 231 watts of solar electricity per person, according to IRENA. Recharging your smart phone uses 6 watts, a common lightbulb uses 60 watts, a coffee machine uses 1,000, a clothes dryer 3,000, and a tankless water heater uses 18,000.

As of 2020, the U.S. produced 3.27% of its primary electricity from solar, according to Our World in Data, and Italy produces 9.66% of its electricity from solar. That’s the most among the most populated countries in the world, (Italy is 23rd largest.)

The five countries that have the most installed capacity and the largest share of solar power in the world are China, the U.S., Japan, Germany, and India.

This list ranks the countries with the highest watts of solar per person. The data come from IRENA and Visual Capitalist.

1. Australia

  • Installed capacity, megawatts: 17,627
  • Watts per capita: 637
  • Share of world total: 2.5%

2. Germany

  • Installed capacity, megawatts: 53,783
  • Watts per capita: 593
  • Share of world total: 7.5% (No. 4 in the world)

3. Japan

  • Installed capacity, megawatts: 67,000
  • Watts per capita: 498
  • Share of world total: 9.4% (No. 3 in the world)

4. Netherlands

  • Installed capacity, megawatts: 10,213
  • Watts per capita: 396
  • Share of world total: 1.4%

5. Belgium

  • Installed capacity, megawatts: 5,646
  • Watts per capita: 394
  • Share of world total: 0.8%

6. Italy

  • Installed capacity, megawatts: 21,600
  • Watts per capita: 345
  • Share of world total: 3.0%

7. Malta

  • Installed capacity, megawatts: 184
  • Watts per capita: 312
  • Share of world total: 0.03%

8. Switzerland

  • Installed capacity, megawatts: 3,118
  • Watts per capita: 295
  • Share of world total: 0.4%

9. Greece

  • Installed capacity, megawatts: 3,247
  • Watts per capita: 258
  • Share of world total: 0.5%

10. Luxembourg

  • Installed capacity, megawatts: 195
  • Watts per capita: 244
  • Share of world total: 0.03%

11. U.S.

  • Installed capacity, megawatts: 75,572
  • Watts per capita: 231
  • Share of world total: 10.6% (No. 2 in the world)

Pictured is a concentrated solar thermal plant in California's Mojave Desert.

12. South Korea

  • Installed capacity, megawatts: 14,575
  • Watts per capita: 217
  • Share of world total: 2.0%

13. United Kingdom

  • Installed capacity, megawatts: 13,563
  • Watts per capita: 200
  • Share of world total: 1.9%

14. Czech Republic

  • Installed capacity, megawatts: 2,073
  • Watts per capita: 194
  • Share of world total: 0.3%

15. Spain

  • Installed capacity, megawatts: 14,089
  • Watts per capita: 186
  • Share of world total: 2.0%

16. Denmark

  • Installed capacity, megawatts: 1,300
  • Watts per capita: 186
  • Share of world total: 0.2%

17. United Arab Emirates

  • Installed capacity, megawatts: 2,539
  • Watts per capita: 185
  • Share of world total: 0.4%

Pictured are solar "trees" in the Sustainability Pavilion at the EXPO 2020 currently going on in Dubai.

18. Austria

  • Installed capacity, megawatts: 2,220
  • Watts per capita: 178
  • Share of world total: 0.3%

19. Taiwan

  • Installed capacity, megawatts: 5,817
  • Watts per capita: 172
  • Share of world total: 0.8%

20. Bulgaria

  • Installed capacity, megawatts: 1,073
  • Watts per capita: 152
  • Share of world total: 0.2%

21. France

  • Installed capacity, megawatts: 11,733
  • Watts per capita: 148
  • Share of world total: 1.6%

22. China

  • Installed capacity, megawatts: 254,355
  • Watts per capita: 147
  • Share of world total: 35.6% (No. 1 in the world)

23. Cyprus

  • Installed capacity, megawatts: 200
  • Watts per capita: 147
  • Share of world total: 0.03%

24. Chile

  • Installed capacity, megawatts: 3,205
  • Watts per capita: 142
  • Share of world total: 0.4%

25. Israel

  • Installed capacity, megawatts: 1,439
  • Watts per capita: 134
  • Share of world total: 0.2%

26. Hungary

  • Installed capacity, megawatts: 1,953
  • Watts per capita: 131
  • Share of world total: 0.3%

27. Slovenia

  • Installed capacity, megawatts: 267
  • Watts per capita: 128
  • Share of world total: 0.04%

28. Ukraine

  • Installed capacity, megawatts: 5,360
  • Watts per capita: 114
  • Share of world total: 0.8%

29. Jordan

  • Installed capacity, megawatts: 1,359
  • Watts per capita: 100
  • Share of world total: 0.2%

30. Estonia

  • Installed capacity, megawatts: 130
  • Watts per capita: 98
  • Share of world total: 0.02%

Explore more of this data at Visual Capitalist.

Read More

Continue Reading

International

UK’s Johnson Urges Talks As Unions Threaten “Biggest Rail Strike In Modern History”

UK’s Johnson Urges Talks As Unions Threaten "Biggest Rail Strike In Modern History"

Authored by Alexander Zhang via The Epoch Times,

British…

Published

on

UK's Johnson Urges Talks As Unions Threaten "Biggest Rail Strike In Modern History"

Authored by Alexander Zhang via The Epoch Times,

British Prime Minister Boris Johnson has urged rail unions to talk to the government before causing “irreparable damage” with strike action.

The National Union of Rail, Maritime, and Transport Workers (RMT) is holding a ballot of its 40,000 members on plans to strike over jobs, pay, and conditions. The ballot is set to close on Tuesday, and the union has claimed that a yes vote could lead to “the biggest rail strike in modern history.”

Another union, the Transport Salaried Staffs’ Association (TSSA), has also warned of a “summer of discontent” with similar action on the way unless pay disputes are resolved.

The prime minister’s official spokesman said on Monday:

“Railways are going through difficult times with passenger numbers down. We need to make sure they’re fit for the future.”

He said the government wants “a fair deal for staff, for passengers, and taxpayers” so that “money isn’t taken away from other essential services” such as the National Health Service.

“The prime minister is firmly of the view that unions should talk to the government before causing irreparable damage to our railways—strikes should be the last resort not the first,” he added.

Transport Secretary Grant Shapps told The Sunday Telegraph that ministers are looking at drawing up laws which would make industrial action illegal unless a certain number of staff are working.

Shapps said the government hopes the unions will “wake up and smell the coffee” and suggested that strikes could put more people off rail travel.

He also accused unions of going straight to industrial action rather than using it as a last resort, adding that railways were already on “financial life support” because of the CCP (Chinese Communist Party) virus pandemic.

Referring to a pledge in the Conservative Party’s 2019 election manifesto, which promised minimum services during rail strikes, he said:

“We had a pledge in there about minimum service levels. If they really got to that point then minimum service levels would be a way to work towards protecting those freight routes and those sorts of things.”

Unions have reacted to the threat with anger.

RMT General Secretary Mick Lynch said, “Any attempt by Grant Shapps to make effective strike action illegal on the railways will be met with the fiercest resistance from RMT and the wider trade union movement.”

He said the government needs to “focus all their efforts on finding a just settlement” to the rail dispute rather than “attack the democratic rights of working people.”

Tyler Durden Tue, 05/24/2022 - 02:00

Read More

Continue Reading

Government

CytoDyn Inc (OTCMKTS: CYDY) On the Comeback Trail (HIV Leronlimab Update)

CytoDyn Inc (OTCMKTS: CYDY) continues to move steadily higher in recent trading since hitting lows of $0.231 after the FDA placed a partial clinical hold…

Published

on

CytoDyn Inc (OTCMKTS: CYDY) continues to move steadily higher in recent trading since hitting lows of $0.231 after the FDA placed a partial clinical hold on the Company’s HIV program and a full clinical hold on its COVID-19 program in the United States. CYDY was one of the biggest runners of 2020 skyrocketing from pennies to $10 per share and MIcrocapdaily covered the stock regularly back in those exciting times. Since than CYDY has been downward bound, first suffering from the Citron short attack and more recently the March 30 drop after the FDA hold. Further, CytoDyn elected to pause its Brazil COVID-19 trials pending results from its previously scheduled data safety monitoring committee meeting and is in the process of reevaluating the timing of its HIV BLA resubmission. CYDY saw further declines after the Company’s CEO and registered public accounting firm, Warren Averett LLC, both resigned. 

On May 23 CYDY reached a non-cash settlement with its former Chief Medical Officer, Dr. Richard Pestell. The Company will release to Dr. Pestell 8.3 million shares of CYDY held in escrow, transfer to Dr. Pestell the assets acquired from ProstaGene LLC and subsequently written-off by the Company and issue a warrant at an exercise price of $0.37 per share to Dr. Pestell for seven million shares of the Company’s common stock. Dr. Pestell and the Company are also exploring ways in which Dr. Pestell can reengage with the Company to help realize Leronlimab’s full potential in oncology. This is an important step forward for CytoDyn as any potential suitor would want the current management to clear the deck of lawsuits before initiating a buyout or partnership. Also, an all-stock settlement shows a lot of faith in the Company from Dr. Pestell who make come back. At this point Cytodyn must find a sponsor or partner to get Leronmilab back on track for HIV. 

The underlying science of Leronmilab has not changed; leronlimab has demonstrated significant potential to attack a number of diseases including cancer, and HIV.  Considering how fast CYDY dropped the bounce potential here is significant and when CYDY does make a definitive move northbound the stock could make rapid gains in a very shorty time period. Management remains hopeful the FDA will review the case and stop the hold of Leronlimab. 

Sign Up now for our 100% FREE Penny Stock Newsletter

CytoDyn Inc (OTCMKTS: CYDY) is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. 

In January Cytodyn reported positive results from the 350 mg weekly dose of its Phase 2 NASH clinical trial. The trial was conducted in two parts. Part 1 compared a 700 mg weekly dose and placebo in a double-blind randomized manner and Part 2 evaluated a 350 mg weekly dose as an open label study compared to the same placebo blinded arm. Results of the topline report will be announced when available.  

The pre-clinical and clinical development of PRO 140 was led by Progenics Pharmaceuticals, Inc. through 2011. The Company acquired the asset from Progenics in October 2012. In February 2018, CYDY announced it had met the primary endpoint in its Phase 3 trial for leronlimab as a combination therapy with HAART for highly treatment-experienced HIV patients and first submitted the non-clinical portion of the Company’s Biologics License Application (“BLA”) to the FDA in March 2019.  

To Find out the inside Scoop on CYDY Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

CYDY

Cytodyns current business strategy is to resubmit its BLA to the FDA as soon as possible, to finalize with the FDA our submitted protocol for a pivotal Phase 3 clinical trial with leronlimab as a monotherapy for HIV patients, to seek emergency use authorization and approval for leronlimab as a potential therapeutic benefit for COVID-19 patients with mild-to-moderate, severe-to-critical, and long-haulers indications in the U.S., Brazil, and other countries, to advance the Company’s clinical trials with leronlimab for various forms of cancer, including, among others, the Phase 2 clinical trial for metastatic triple-negative breast cancer and Phase 2 basket trial for 22 solid tumor cancers, to complete the Phase 2 trial for liver fibrosis associated with nonalcoholic steatohepatitis (“NASH”), and to explore other cancer and immunologic indications for leronlimab.  

On May 23 CYDY announced it has reached a non-cash settlement with its former Chief Medical Officer, Dr. Richard Pestell, concerning an ongoing legal dispute related to his former employment with the Company. 

Under the terms of the agreement, the parties will release each other of all claims, and the Company will release to Dr. Pestell 8.3 million shares of the Company’s common stock held in escrow, transfer to Dr. Pestell the assets acquired from ProstaGene LLC and subsequently written-off by the Company and issue a warrant at an exercise price of $0.37 per share to Dr. Pestell for seven million shares of the Company’s common stock. Dr. Pestell and the Company are also exploring ways in which Dr. Pestell can reengage with the Company to help realize leronlimab’s full potential in oncology. CytoDyn regrets Dr. Pestell’s departure from the Company and the subsequent public statements made by its former CEO about Dr. Pestell. 

Dr. Pestell has published more than 600 works, is the most frequently cited scientist in the field of cell-cycle control and was appointed an Officer of the Order of Australia in the 2019 Queen’s Birthday Honours for distinguished service to medicine and medical education. He has served on editorial boards of six journals, was the Director of two NCI-designated Cancer Centers and has founded several biotechnology companies. He serves as an advisor and reviewer for a number of domestic and international research centers, including NCI cancer centers. 

For More on CYDY Subscribe Right Now!

Currently trading at a $226 million market valuation CYDY is an SEC filer and is fully reporting OTCQB. The Company has close to $100 million in assets and about that in debt. At current price levels CYDY is worth a close look; CYDY was one of the biggest runners of 2020 skyrocketing from pennies to $10 per share. While there are plenty of ricks not to mention the CEO and accounting firm resigning CYDY is moving northbound now and looks to be coming back. The underlying science has not changed; Leronlimab has demonstrated significant potential to attack a number of diseases including cancer and HIV.  Considering how fast CYDY dropped the bounce potential here is significant and when CYDY does make a definitive move northbound the stock could make rapid gains in a very shorty time period. Management remains hopeful the FDA will review the case and stop the hold of Leronlimab. We will be updating on CYDY when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CYDY.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in CYDY either long or short and we have not been compensated for this article.

The post CytoDyn Inc (OTCMKTS: CYDY) On the Comeback Trail (HIV Leronlimab Update) first appeared on Micro Cap Daily.

Read More

Continue Reading

International

How Inflation Changed The Price Of A Burger

How Inflation Changed The Price Of A Burger

With inflation standing at 8.3% year-over-year in April, everyday items are becoming pricier…

Published

on

How Inflation Changed The Price Of A Burger

With inflation standing at 8.3% year-over-year in April, everyday items are becoming pricier for U.S. consumers. As Statista's Katharina Buchholz details below, food prices in particular took some significant steps up, as seen in the example of shopping for hamburger ingredients.

You will find more infographics at Statista

Meats experienced some of the highest price increases among food items: Ground beef now costs almost 15 percent more than in April 2021 and bacon is 17.7 percent more expensive than one year ago.

On the other hand, the price of tomatoes was up just 0.4 percent over the course of one year, showing that some item suffered less inflation than others.

At a 6.2 percent price increase, fresh vegetables as a whole saw the lowest rate of inflation of any food category.

Energy – the most volatile item in the Consumer Price Index together with foods - drove overall price increases even more. In short supply following the Russian invasion of Ukraine and ensuing sanctions, energy costs rose by 30.3 percent since April 2021. This increase is independent of the base effect as energy prices had already reached pre-pandemic levels again one year ago.

Inflation had already started to rise in 2021 in the aftermath of Covid-19 lockdowns that continue to affect global supply chains. It was further pushed up by the Russian invasion of Ukraine that saw energy supply disrupted by sanctions and Ukrainian products missing from world markets. As a result, inflation is reaching an increasingly broad range of products. For example, while the price of used cars and trucks had already skyrocketed in 2021, new vehicles have now also become 13 percent more expensive than they had been a year ago.

Given the high price of gas and cars, inflation is indirectly encouraging another behavior - using public transportation. The category became 2.7 percent more expensive over the past year.

Tyler Durden Mon, 05/23/2022 - 22:00

Read More

Continue Reading

Trending